magnetic resonance therapy: the prostate program

25
©2005 Surgical Planning Laboratory, ARR Slide 1 Magnetic Resonance Therapy: The Prostate program Clare Tempany MD Director, MRT Program leader & Core Leader

Upload: dylan-hunt

Post on 01-Jan-2016

22 views

Category:

Documents


0 download

DESCRIPTION

Magnetic Resonance Therapy: The Prostate program. Clare Tempany MD Director, MRT Program leader & Core Leader. Prostate cancer: Scope of the problem. 1.5 million prostate biopsies per year 25 million men have had at least one negative biopsy 2003- 220,900 New cases were diagnosed - PowerPoint PPT Presentation

TRANSCRIPT

  • Chart1

    06535

    0982

    54545

    &A

    Page &P

    PZ

    Urethra

    Ant Rect

    Sheet1

    Ant RectUrethraPZ

    PZ005

    Urethra659845

    Ant Rect35245

    PZUrethraAnt Rect

    500

    459865

    45235

    &A

    Page &P

    2005 Surgical Planning Laboratory, ARRSlide *

    Contouring PZ, urethra and rectum Axial T2W image Treatment plan

    2005 Surgical Planning Laboratory, ARRSlide *

    Needle PlacementNeedle InsertionRT ImagingCor,Sag,AxRadio logicEvaluationDosimetric EvaluationPlace SeedsDose EvaluationPlan ModificationRepositionNeedleNext NeedleAdditional Needles Necessary?Feedbacks:AnatomicGeometricDosimetricYesYesNoNo

    2005 Surgical Planning Laboratory, ARRSlide *

    Brachytherapy planning Software** US PATENT OFFICERadiation seed implant method and apparatus. JCR098-01pA: 2001, Nov 1.

    2005 Surgical Planning Laboratory, ARRSlide *

    MR-guided prostate biopsy programClinical needTRUS high false negativeMR Bx Target +Sextant/octantNeed target validation methodNeed free-hand or Robot assisted approachTARGET3D-Slicer adapted for prostate procedures and target definition, trajectory planning and guidance

    2005 Surgical Planning Laboratory, ARRSlide *

    MR guided biopsy protocolPre-biopsyMR imagingDefine any targetsT2WContrastMRSILSDIT2 mapsBiopsyOpen MRTTransperinealTargeted samplingSystematic sampling (Sextant/Octant)Site specific pathology

    2005 Surgical Planning Laboratory, ARRSlide *

    MRI/MRSI : Data SummaryUp to1024ProstatespectraData from UCSF Kurhanewicz et al

    2005 Surgical Planning Laboratory, ARRSlide *

    Multi-parametric and multi- modal data problem

    2005 Surgical Planning Laboratory, ARRSlide *

    [11C] Choline PET/MRIPETFUSIONMRICourtesy of J. Czernin, MD Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA

    2005 Surgical Planning Laboratory, ARRSlide *

    Prostate IGT Research projectsRegistration & SegmentationMulti-modal image displaySeed definition-seed based dosimetryClinical outcomesCancer diagnosis, control, toxicity and QOLTarget definitionMulti-parametric data analysis and summationOptimized biopsyDavatzikos et al-mathematical statistical modelRobotic assist device /closed bore systemsFichtinger, Burdette et alMRg Prostate cancer FUSHynynen et al

    2005 Surgical Planning Laboratory, ARRSlide *

    Interfractional Motion from Serial CT Movement AP ~1cm*Courtesy of Andrew Zitman MD (MGH) IGT requires dynamic imaging to monitor delivery: Rapid image processing & registration

    2005 Surgical Planning Laboratory, ARRSlide *

    Recent case: Rising PSA 4 years after brachytherapy

    2005 Surgical Planning Laboratory, ARRSlide *

    MR/MRSI guided biopsy & Rx

    AdenocarcinomaAnterior TZ

    2005 Surgical Planning Laboratory, ARRSlide *

    MR guided brachytherapy: Clinical validation / outcomesOutcomes. Albert* et al Cancer (2003)Grade 3 rectal bleeding 8% vs. 30% (combined)4yr freedom from Radiation cystitis: 100 vs. 95%No urethral strictures or TURP to dateCancer control DAmico et al (2003) 93% 5 yr PSA control, similar to a surgically managed population over the same time frameQOL: Szot* et al RSNA 2004Significant improvement over US in both GU and sexual function* R25 training grant fellows

    2005 Surgical Planning Laboratory, ARRSlide *

    Non-invasive Focused ultrasound surgeryHigh intensity FUS first proposed by Lele in 1962Sound waves heat tissue through molecular vibrationDelay due to lack of targeting, guidance and temperature monitoringTested in animals-nude mouse model- Vaezy S et alFeasible for treating Breast Fibroadenomas-Hynenen K, et al Feasible for treating uterine Leiomyomas-Tempany et al

    2005 Surgical Planning Laboratory, ARRSlide *

    Future directions; MR guided Focused Ultrasound Surgery for Prostate cancer*

    FUS THERMO-COAGULATIONnecrosisReal timeMR thermometry*R01: CA-109246-01 A1 Tempany

  • This movie loop shows the movement of the soft tissues after reasonable image registration of the bony anatomy from 6 serial volumetric CT studies. We have seen the standard deviations from previous speakers, and this is just a graphic illustration of what this really is about. These displays also provide information on structures for which COM data are not given.